Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Covigenix
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Entos Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
Cytiva and Entos Pharmaceuticals work together to accelerate development of COVID19 vaccines
Details : Cytiva’s Fast Trak process development team will use their expertise to develop a scalable downstream protein purification method that will enable GMP-production of the Fusogenix protein component that facilitates intracellular DNA delivery.
Brand Name : Undisclosed
Molecule Type : Vaccine
Upfront Cash : Undisclosed
June 01, 2020
Lead Product(s) : Covigenix
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Entos Pharmaceuticals
Deal Size : Undisclosed
Deal Type : Collaboration
LOOKING FOR A SUPPLIER?
Reset All
